Patient One Products

Patient One's premier line of MediNutritional products is available exclusively through health care practitioners. Our advanced, science-based nutritional supplements are designed to optimize your patients’ health and support you in providing superior care for your patients.

Ubiquinol™ 100 mg (vege softgels)

Active antioxidant form of CoQ10 with superior bioavailability in adults over age 40

Unique Properties

Patient One Ubiquinol 100 mg supplies the active antioxidant form of Coenzyme Q10, known for its superior bioavailability and absorption in adults over 40. Ubiquinol is responsible for the powerful benefits traditionally associated with CoQ10, and makes up over 95% of the total CoQ10 in the plasma of a healthy individual. Young healthy individuals can make their own CoQ10 and convert it into Ubiquinol but as we age, our ratio of Ubiquinol to CoQ10 may decrease as a result of oxidative stress.

Key Ingredients

Ubiquinol™ 100 mg

As the active, more readily available form of Coenzyme Q10 from Kaneka, Ubiquinol sparks energy production in the mitochondria of every cell in the human body while providing potent antioxidant protection against free radical damage. Ubiquinol optimizes overall cardiovascular wellness by promoting myocardial energy production, healthy circulation, vascular integrity and blood pressure that is already within in a normal range.

Concentrated in the heart, ubiquinol has been found to be suppressed in those with cardiovascular issues. Ubiquinol provides an active defense against oxidative damage to lipids, proteins and DNA.

Statin Drugs and Ubiquinol

Supplemental ubiquinol helps to reverse the CoQ10 depletion sometimes associated with cholesterol-lowering statin drugs. From 2000 to 2005, spending on statins increased 156% and the number of people taking statins increased to 30 million.3

While statin drugs help many Americans’ heart health, they present a paradoxical side effect: statin drugs inhibit CoQ10 production in the body, which may leave the heart susceptible to a number of different negative health conditions. The good news: Experts believe that statin drug-induced CoQ10 deficiency may be “completely [reversible] with supplemental CoQ10” 7– thus restoring heart health-promoting energy and antioxidant protection.

Enhanced Bioavailability

Research suggests smaller servings of Ubiquinol appear far more efficient at raising plasma levels of CoQ10 (see chart below). In fact, one study suggests that those taking Ubiquinol had a 430% increase in plasma levels, compared to those taking CoQ10 alone.6

CoQ10 levels decline with age, and supplemental CoQ10 is difficult for those over age 40 to absorb. For these patients and patients taking statin drugs, Patient One Ubiquinol 100 mg is an ideal way to gain CoQ10’s nutritional wellness benefits.

Research

Ubiquinol (CoQ10) Cardiological Study: Over 1,100 patients with heart concerns were given 50-150 mg of CoQ10 daily for three months. At study’s end, cardiologists reported that 80% of the patients enjoyed positive results by taking CoQ10 as a complementary therapy. Overall, 54% of subjects enjoyed improvement in three or more heart symptoms, which researchers interpreted as an enhancement in quality of life.(1)

1,715 patients with heart concerns were given 50 mg CoQ10 daily for only four weeks while still receiving conventional therapy. The study authors reported that CoQ10, in conjunction with conventional treatment, was associated with significant improvement. Physicians’ assessment of the patients was also positive, with 86.5% reporting “fairly good” to “excellent” CoQ10 therapy results.(2)

Peter H. Langsjoen, M.D., F.A.c.c. The clinical use of HMG CoAreductase inhibitors (statins) and the associated depletion of the essential co-factor coenzyme Qlo; a review of pertinent human and animal data.

Langsjoen, PH et al. Biofactors. 2003; 18(1-4)101-11.

Evans M, et al. A randomized, double-blind trial on the bioavailability of two CoQ10 formulations. Journal of Functional Foods I (2009) 65-73.